Literature DB >> 25591862

ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Alison B Kohan1, Fei Wang2, Chun-Min Lo2, Min Liu2, Patrick Tso2.   

Abstract

Apolipoprotein A-IV (apoA-IV) is secreted by the small intestine on chylomicrons into intestinal lymph in response to fat absorption. Many physiological functions have been ascribed to apoA-IV, including a role in chylomicron assembly and lipid metabolism, a mediator of reverse-cholesterol transport, an acute satiety factor, a regulator of gastric function, and, finally, a modulator of blood glucose homeostasis. The purpose of this review is to update our current view of intestinal apoA-IV synthesis and secretion and the physiological roles of apoA-IV in lipid metabolism and energy homeostasis, and to underscore the potential for intestinal apoA-IV to serve as a therapeutic target for the treatment of diabetes and obesity-related disease.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  apolipoprotein A-IV (apoA-IV); cardiovascular disease; chylomicron; diabetes; glucose homeostasis; intestinal lipid transport; lymph fistula mouse model; obesity; satiety

Mesh:

Substances:

Year:  2015        PMID: 25591862      PMCID: PMC4360046          DOI: 10.1152/ajpgi.00098.2014

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  104 in total

1.  Apolipoprotein A-IV messenger ribonucleic acid abundance is regulated in a tissue-specific manner.

Authors:  B Staels; A van Tol; G Verhoeven; J Auwerx
Journal:  Endocrinology       Date:  1990-04       Impact factor: 4.736

2.  Fat feeding increases size, but not number, of chylomicrons produced by small intestine.

Authors:  H Hayashi; K Fujimoto; J A Cardelli; D F Nutting; S Bergstedt; P Tso
Journal:  Am J Physiol       Date:  1990-11

3.  Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation.

Authors:  K Fujimoto; J A Cardelli; P Tso
Journal:  Am J Physiol       Date:  1992-06

4.  Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat.

Authors:  H Hayashi; D F Nutting; K Fujimoto; J A Cardelli; D Black; P Tso
Journal:  J Lipid Res       Date:  1990-09       Impact factor: 5.922

Review 5.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

6.  Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes.

Authors:  R B Weinberg; C S Patton
Journal:  Biochim Biophys Acta       Date:  1990-05-22

7.  Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.

Authors:  K Fujimoto; K Fukagawa; T Sakata; P Tso
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass.

Authors:  Derek M Culnan; Robert N Cooney; Bruce Stanley; Christopher J Lynch
Journal:  Obesity (Silver Spring)       Date:  2008-10-23       Impact factor: 5.002

9.  Capsaicin-sensitive vagal afferents and CCK in inhibition of gastric motor function induced by intestinal nutrients.

Authors:  H E Raybould
Journal:  Peptides       Date:  1991 Nov-Dec       Impact factor: 3.750

10.  Comparison of the satiating potencies of cholecystokinin-33 and cholecystokinin-8.

Authors:  L D Melville; G P Smith; J Gibbs
Journal:  Pharmacol Biochem Behav       Date:  1993-05       Impact factor: 3.533

View more
  21 in total

1.  Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.

Authors:  Diana K Costa; Brydie R Huckestein; Lia R Edmunds; Max C Petersen; Ali Nasiri; Gina M Butrico; Abudukadier Abulizi; Daniel B Harmon; Canying Lu; Benjamin S Mantell; Douglas J Hartman; João-Paulo G Camporez; Robert M O'Doherty; Gary W Cline; Gerald I Shulman; Michael J Jurczak
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-10       Impact factor: 4.310

2.  Apolipoprotein A-IV constrains HPA and behavioral stress responsivity in a strain-dependent manner.

Authors:  Amy E B Packard; Jintao Zhang; Brent Myers; Chih-Wei Ko; Fei Wang; Patrick Tso; Yvonne M Ulrich-Lai
Journal:  Psychoneuroendocrinology       Date:  2017-09-01       Impact factor: 4.905

3.  Biliopancreatic Diversion Decreases Postprandial Apolipoprotein A-IV Levels in Mildly Obese Individuals with Type 2 Diabetes Mellitus: a Prospective Study.

Authors:  Everton Cazzo; José Carlos Pareja; Bruno Geloneze; Elinton Adami Chaim; Maria Rita Lazzarini Barreto; Daniéla Oliveira Magro
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

4.  c-MAF coordinates enterocyte zonation and nutrient uptake transcriptional programs.

Authors:  Alejandra González-Loyola; Jeremiah Bernier-Latmani; Irena Roci; Tania Wyss; Jakob Langer; Stephan Durot; Olivia Munoz; Borja Prat-Luri; Mauro Delorenzi; Matthias P Lutolf; Nicola Zamboni; Grégory Verdeil; Tatiana V Petrova
Journal:  J Exp Med       Date:  2022-09-19       Impact factor: 17.579

5.  Apolipoprotein A-IV enhances cholecystokinnin secretion.

Authors:  Jesse Zhan; Jonathan Weng; Brian G Hunt; W Sean Davidson; Min Liu; Chunmin C Lo
Journal:  Physiol Behav       Date:  2018-01-31

6.  Apolipoprotein A-IV Enhances Fatty Acid Uptake by Adipose Tissues of Male Mice via Sympathetic Activation.

Authors:  Qi Zhu; Jonathan Weng; Minqian Shen; Jace Fish; Zhujun Shen; Karen T Coschigano; W Sean Davidson; Patrick Tso; Haifei Shi; Chunmin C Lo
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

Review 7.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 8.  Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

Authors:  Emilie Crouchet; Thomas F Baumert; Catherine Schuster
Journal:  Expert Rev Proteomics       Date:  2017-06-30       Impact factor: 4.250

9.  A genome-wide association meta-analysis on apolipoprotein A-IV concentrations.

Authors:  Claudia Lamina; Salome Friedel; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Barbara Kollerits; Pedro Marques-Vidal; Janina Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Stefan Kiechl; Olli T Raitakari; Mika Kähönen; Johann Willeit; Ludmilla Kedenko; Bernhard Paulweber; Annette Peters; Thomas Meitinger; Konstantin Strauch; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Florian Kronenberg
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

10.  Evaluating the Causal Relation of ApoA-IV with Disease-Related Traits - A Bidirectional Two-sample Mendelian Randomization Study.

Authors:  Salome Mack; Stefan Coassin; Julien Vaucher; Florian Kronenberg; Claudia Lamina
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.